Biotechnology Value Fund II LP
Biotechnology Value Fund II LP is a hedge fund based in San Francisco, California. According to its most recent Form D, filed Dec 23, 2025, the fund has sold $1,406,935,818 of interests to 123 investors since its first sale in Sep 2008. The minimum investment it accepts from an outside investor is $25,000,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include BVF II GP LLC; BVF GP Holdings LLC; BVF Partners, L.P.
Performance
No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $1,406,935,818Cumulative sales reported on Form D
- Investors
- 123
- First sale
- Sep 1, 2008
- Minimum investment
- $25,000,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- BVF II GP LLC; BVF GP Holdings LLC; BVF Partners, L.P
- Latest Form D
- Dec 23, 2025
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Dec 23, 2025 | Form D/A (amendment) | $1,406,935,818 | 123 | SEC.gov ↗ |
| Dec 27, 2024 | Form D/A (amendment) | $1,325,635,818 | 118 | SEC.gov ↗ |
| Dec 29, 2023 | Form D/A (amendment) | $1,278,335,818 | 115 | SEC.gov ↗ |
| Dec 30, 2022 | Form D/A (amendment) | $1,260,272,818 | 114 | SEC.gov ↗ |
| Jan 4, 2022 | Form D/A (amendment) | $1,035,372,818 | 101 | SEC.gov ↗ |
| Jan 7, 2021 | Form D/A (amendment) | $584,922,818 | 68 | SEC.gov ↗ |
| Jan 10, 2020 | Form D/A (amendment) | $487,122,818 | 60 | SEC.gov ↗ |
| Jan 11, 2019 | Form D/A (amendment) | $210,422,818 | 38 | SEC.gov ↗ |
| Dec 8, 2017 | Form D/A (amendment) | $193,222,818 | 36 | SEC.gov ↗ |
| Sep 21, 2016 | Form D/A (amendment) | $179,922,818 | 34 | SEC.gov ↗ |
| Nov 12, 2014 | Form D/A (amendment) | $46,100,000 | 14 | SEC.gov ↗ |
11 Form D filings in the SEC's electronic records (2008 onward), the earliest on Nov 12, 2014. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Foundations that report holding this fund
| Foundation | State | Value reported | Basis | Tax year ended |
|---|---|---|---|---|
| Michael & Susan Dell Foundation | TX | $84,248,086 | fair market value | Dec 31, 2024 |
| Hillman Family Foundations | PA | $14,611,124 | fair market value | Dec 31, 2024 |
| The Schmidt Family Foundation | CA | $6,818,524 | fair market value | Dec 31, 2024 |
| The Eric and Wendy Schmidt Fund for | CA | $4,285,908 | fair market value | Dec 31, 2024 |
4 private foundations listed this fund by name among the investments on their IRS Form 990-PF. The value is the year-end figure the foundation reported, exactly as filed (fair market value where given, otherwise book value); holdings may have changed since, and other investors in the fund are not listed. Matched by the fund's full name; not verified by AltMountain or by the fund. Source: Internal Revenue Service, Form 990 series e-file data.
Questions about Biotechnology Value Fund II LP
What is the minimum investment for Biotechnology Value Fund II LP?
According to its latest Form D, filed Dec 23, 2025, the minimum investment Biotechnology Value Fund II LP accepts from an outside investor is $25,000,000.
Who can invest in Biotechnology Value Fund II LP?
Biotechnology Value Fund II LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Biotechnology Value Fund II LP raised?
Biotechnology Value Fund II LP reports $1,406,935,818 sold from 123 investors on its Form D filed Dec 23, 2025. This is cumulative sales since the offering began, not current assets or performance.
Where is Biotechnology Value Fund II LP based?
Biotechnology Value Fund II LP is based in San Francisco, California and is managed by BVF Partners L.P..
When did Biotechnology Value Fund II LP launch?
Biotechnology Value Fund II LP reports its first sale in Sep 2008.
Size compared with every hedge fund
Raised more than 94% of the 1,049 hedge funds based in California, and more than 93% of all 10,141 that report sales.